J. Delaloye

Discipline

Sociologie (1) Psychologie (1) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (15) Recensions (3)

Co-auteur

Date

Source

Mot-clé

Patients (8) Human beings (8) Patients (8) Infection (7) Cells (7) puits (6) infection (6) virus (5) thérapie (5) vecteur (5) Treatment (5) Therapeutics (5) Expression (5) gène (4) Case (4) Vaccinia (4) Mice (4) Macrophages (4) Grammar, Comparative and general--Case (4) Case (4) Use (4) protéine (3) antibiotique (3) immunité (3) histoire (3) ADN (3) Diagnosis (3) Deletion (3) History (3) Cases (3)

Documents écrit par J. Delaloye (15) | parle de J. Delaloye (0)

Investigating nanomotion-based technology (Resistell AST) for rapid antibiotic susceptibility testing among adult patients admitted to a tertiary-care hospital with Gram-negative bacteraemia: protocol for a prospective, observational, cross-sectional, single-arm study.
G. Caruana et al. (21 nov. 2022)
Serum antibody response in critically ill patients with COVID-19.
A. Longchamp et al.
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis.
A. Longchamp et al.
Culture-independent genome sequencing of Coxiella burnetii from a native heart valve of a Tunisian patient with severe infective endocarditis.
J. Delaloye et al.
Update of the Swiss guidelines on post-treatment Lyme disease syndrome.
J. Nemeth et al. (2016)
Tropheryma whipplei bivalvular endocarditis and polyarthralgia: a case report.
J.R. Gruber et al. (2015)
Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
J. Delaloye et al. (2015)
Invasive candidiasis as a cause of sepsis in the critically ill patient.
J. Delaloye et al. (2014)
Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C.
B. Perdiguero et al. (2013)
Macrophage Migration Inhibitory Factor Deficiency Is Associated With Impaired Killing of Gram-Negative Bacteria by Macrophages and Increased Susceptibility to Klebsiella pneumoniae Sepsis.
T. Roger et al. (2013)
Fievre Q: une zoonose souvent méconnue [Q fever, a zoonosis often overlooked].
J. Delaloye et al. (2013)
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.
C.E. Gómez et al. (2012)
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens.
B. Perdiguero et al. (2012)
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.
J. Delaloye et al. (2009)
Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?
J. Delaloye et al. (2004)